Newly Designed Fully Covered Metal Stent for the Benign Biliary Stricture

NCT ID: NCT00945516

Last Updated: 2010-10-19

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

PHASE3

Total Enrollment

60 participants

Study Classification

INTERVENTIONAL

Study Start Date

2009-01-31

Study Completion Date

2010-05-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The purpose of this study is to determine the feasibility, easy removability, safety, and migration rate of flared end fully covered self-expanding metal stent (FCSEMS) and anchoring FCSEMS for benign biliary stricture.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Benign biliary strictures (BBS) are usually managed with plastic stents, whereas placement of uncovered metallic stents has been associated with failure related to mucosal hyperplasia. Fully covered self-expanding metal stent(FCSEMS) placement was reported as a useful method for BBS. However, stent migration was a frequent complication of CSEMS placement. Recently, flared end FCSEMS was developed to decrease stent migration, and anchoring CSEMS was newly developed.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Bile Duct Disease

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Flared end FCSEMS

Flared end FCSEMS will be inserted for the benign bile duct stricture.

Group Type ACTIVE_COMPARATOR

Bona stent® (Flared end FCSEMS)

Intervention Type DEVICE

Flared end FCSEMS for benign bile duct stricture will be inserted with ERCP.

Anchoring FCSEMS

Anchoring FCSEMS will be inserted for benign bile duct stricture

Group Type ACTIVE_COMPARATOR

Hanarostent® (Anchoring FCSEMS)

Intervention Type DEVICE

Anchoring FCSEMS for benign bile duct stricture will be inserted with ERCP.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Bona stent® (Flared end FCSEMS)

Flared end FCSEMS for benign bile duct stricture will be inserted with ERCP.

Intervention Type DEVICE

Hanarostent® (Anchoring FCSEMS)

Anchoring FCSEMS for benign bile duct stricture will be inserted with ERCP.

Intervention Type DEVICE

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

Bona stent® (Sewoon medical Co., LTD., Seoul, Korea) Hanarostent® (M.I.Tech, Seoul, Korea)

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Patient over 18 years old
* Patient with benign bile duct stricture

Exclusion Criteria

* No written informed consent
* Malignant biliary obstruction
* Patients with uncorrectable severe coagulopathy
* Patients with severe cardiopulmonary disease precluding sedation
Minimum Eligible Age

18 Years

Maximum Eligible Age

80 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Asan Medical Center

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Asan Medical Center

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Do Hyun Park, MD, PhD

Role: STUDY_DIRECTOR

Department of Gastroenterology, University of Ulsan College of Medicine, Asan Medical Center

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Asan Medical Center

Seoul, Seoul, South Korea

Site Status

Countries

Review the countries where the study has at least one active or historical site.

South Korea

References

Explore related publications, articles, or registry entries linked to this study.

Park DH, Lee SS, Lee TH, Ryu CH, Kim HJ, Seo DW, Park SH, Lee SK, Kim MH, Kim SJ. Anchoring flap versus flared end, fully covered self-expandable metal stents to prevent migration in patients with benign biliary strictures: a multicenter, prospective, comparative pilot study (with videos). Gastrointest Endosc. 2011 Jan;73(1):64-70. doi: 10.1016/j.gie.2010.09.039.

Reference Type DERIVED
PMID: 21184871 (View on PubMed)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

2009-0233

Identifier Type: -

Identifier Source: org_study_id